Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P A DeSimone

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Neurology|August 1, 1978
Hypoglossal nerve palsy in infectious mononucleosisP A DeSimone, D Snyder
American Journal of Clinical Oncology|October 1, 1984
Phase II studies of mitoxantrone (dihydroxyanthracenedione) in the treatment of advanced colorectal carcinomaP A DeSimone, R Gams, A Bartolucci
Human Pathology|September 1, 1980
Phagocytic tumor cell activity in oat cell carcinoma of the lungP A DeSimone, R East, R D Powell
Thyroid : Official Journal of the American Thyroid Association|August 25, 2000
Treatment of anaplastic thyroid carcinoma with paclitaxel: phase 2 trial using ninety-six-hour infusion. Collaborative Anaplastic Thyroid Cancer Health Intervention Trials (CATCHIT) GroupK B Ain, M J Egorin, P A DeSimone
Cancer Treatment Reports|November 1, 1979
Phase I evaluation of a weekly schedule of anguidine. Southeastern Cancer Study Group Committee on Gastrointestinal MalignanciesP A DeSimone, F A Greco, H F Lessner
American Journal of Clinical Oncology|June 1, 1986
Phase I-II evaluation of razoxane (ICRF-159) and doxorubicin in gastrointestinal cancer. A Southeastern Cancer Study Group TrialP A DeSimone, F A Greco, G A Omura, et al.
American Journal of Clinical Oncology|June 1, 1986
Phase II evaluation of anguidine (NSC 141537) in 5-day courses in colorectal adenocarcinoma. A Southeastern Cancer Study Group TrialP A DeSimone, F A Greco, H F Lessner, et al.
Annals of Internal Medicine|June 15, 1992
The accelerated internal medicine program at the University of KentuckyJ S Thompson, S A Haist, P A DeSimone, et al.
Cancer Treatment Reports|June 1, 1979
Effect of a forced diuresis on the distribution and excretion (via urine and bile) of 195mplatinum when given as 195mplatinum cis-dichlorodiammineplatinum(II)P A DeSimone, R S Yancey, J J Coupal, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Neurology|August 1, 1978
Hypoglossal nerve palsy in infectious mononucleosisP A DeSimone, D Snyder
American Journal of Clinical Oncology|October 1, 1984
Phase II studies of mitoxantrone (dihydroxyanthracenedione) in the treatment of advanced colorectal carcinomaP A DeSimone, R Gams, A Bartolucci
Human Pathology|September 1, 1980
Phagocytic tumor cell activity in oat cell carcinoma of the lungP A DeSimone, R East, R D Powell
Thyroid : Official Journal of the American Thyroid Association|August 25, 2000
Treatment of anaplastic thyroid carcinoma with paclitaxel: phase 2 trial using ninety-six-hour infusion. Collaborative Anaplastic Thyroid Cancer Health Intervention Trials (CATCHIT) GroupK B Ain, M J Egorin, P A DeSimone
Cancer Treatment Reports|November 1, 1979
Phase I evaluation of a weekly schedule of anguidine. Southeastern Cancer Study Group Committee on Gastrointestinal MalignanciesP A DeSimone, F A Greco, H F Lessner
American Journal of Clinical Oncology|June 1, 1986
Phase I-II evaluation of razoxane (ICRF-159) and doxorubicin in gastrointestinal cancer. A Southeastern Cancer Study Group TrialP A DeSimone, F A Greco, G A Omura, et al.
American Journal of Clinical Oncology|June 1, 1986
Phase II evaluation of anguidine (NSC 141537) in 5-day courses in colorectal adenocarcinoma. A Southeastern Cancer Study Group TrialP A DeSimone, F A Greco, H F Lessner, et al.
Annals of Internal Medicine|June 15, 1992
The accelerated internal medicine program at the University of KentuckyJ S Thompson, S A Haist, P A DeSimone, et al.
Cancer Treatment Reports|June 1, 1979
Effect of a forced diuresis on the distribution and excretion (via urine and bile) of 195mplatinum when given as 195mplatinum cis-dichlorodiammineplatinum(II)P A DeSimone, R S Yancey, J J Coupal, et al.
Pageof 1